Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome
- PMID: 16284256
- PMCID: PMC2563164
- DOI: 10.1136/jmg.2005.038604
Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome
Abstract
Introduction: The 22q13.3 deletion syndrome (MIM 606232) is characterised by neonatal hypotonia, normal to accelerated growth, absent to severely delayed speech, global developmental delay, and minor dysmorphic facial features. We report the molecular characterisation of the deletion breakpoint in two unrelated chromosome 22q13.3 deletion cases.
Methods: The deletions were characterised by FISH, checked for other abnormalities by array-CGH, and confirmed by Real-Time PCR, and finally the breakpoints were cloned, sequenced, and compared.
Results: Both cases show the cardinal features of the 22q13.3 deletion syndrome associated with a deletion involving the last 100 kb of chromosome 22q13.3. The cases show a breakpoint within the same 15 bp repeat unit, overlapping the results obtained by Wong and colleagues in 1997 and suggesting that a recurrent deletion breakpoint exists within the SHANK3 gene. The direct repeat involved in these 22q13 deletion cases is presumably able to form slipped (hairpin) structures, but it also has a strong potential for forming tetraplex structures.
Discussion: Three cases with a common breakpoint within SHANK3 share a number of common phenotypic features, such as mental retardation and developmental delay with severely delayed or absent expressive speech. The two cases presented here, having a deletion partially overlapping the commercial subtelomeric probe, highlight the difficulties in interpreting FISH results and suggest that many similar cases may be overlooked.
Conflict of interest statement
Competing interests: none declared
Similar articles
-
Chromosome 22q13.3 deletion syndrome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3.Eur J Med Genet. 2009 Sep-Oct;52(5):328-32. doi: 10.1016/j.ejmg.2009.05.004. Epub 2009 May 18. Eur J Med Genet. 2009. PMID: 19454329
-
Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome.Am J Hum Genet. 2001 Aug;69(2):261-8. doi: 10.1086/321293. Epub 2001 Jun 18. Am J Hum Genet. 2001. PMID: 11431708 Free PMC article.
-
Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation.Eur J Hum Genet. 2005 Sep;13(9):1019-24. doi: 10.1038/sj.ejhg.5201456. Eur J Hum Genet. 2005. PMID: 15986041
-
A previously unrecognized 22q13.2 microdeletion syndrome that encompasses TCF20 and TNFRSF13C.Am J Med Genet A. 2018 Dec;176(12):2791-2797. doi: 10.1002/ajmg.a.40492. Epub 2018 Sep 14. Am J Med Genet A. 2018. PMID: 30216695 Review.
-
Late-onset epileptic spasms in a patient with 22q13.3 deletion syndrome.Brain Dev. 2016 Jan;38(1):109-12. doi: 10.1016/j.braindev.2015.06.002. Epub 2015 Jun 17. Brain Dev. 2016. PMID: 26094094 Review.
Cited by
-
The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders.Trends Neurosci. 2009 Jul;32(7):402-12. doi: 10.1016/j.tins.2009.04.003. Epub 2009 Jun 21. Trends Neurosci. 2009. PMID: 19541375 Free PMC article. Review.
-
Further delineation of nonhomologous-based recombination and evidence for subtelomeric segmental duplications in 1p36 rearrangements.Hum Genet. 2009 Jun;125(5-6):551-63. doi: 10.1007/s00439-009-0650-9. Epub 2009 Mar 7. Hum Genet. 2009. PMID: 19271239
-
Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3.Hum Mol Genet. 2011 Aug 1;20(15):3093-108. doi: 10.1093/hmg/ddr212. Epub 2011 May 10. Hum Mol Genet. 2011. PMID: 21558424 Free PMC article.
-
Selection for the G4 DNA motif at the 5' end of human genes.Mol Carcinog. 2009 Apr;48(4):319-25. doi: 10.1002/mc.20496. Mol Carcinog. 2009. PMID: 19306310 Free PMC article.
-
Stem cell-derived neurons from autistic individuals with SHANK3 mutation show morphogenetic abnormalities during early development.Mol Psychiatry. 2018 Mar;23(3):735-746. doi: 10.1038/mp.2017.185. Epub 2017 Sep 26. Mol Psychiatry. 2018. PMID: 28948968 Free PMC article.
References
-
- Knight S J, Flint J. The use of subtelomeric probes to study mental retardation. Methods Cell Biol 200475799–831. - PubMed
-
- Willatt L, Cox J, Barber J, Cabanas E D, Collins A, Donnai D, Fitzpatrick D R, Maher E, Martin H, Parnau J, Pindar L, Ramsay J, Shaw‐Smith C, Sistermans E A, Tettenborn M, Trump D, de Vries B B, Walker K, Raymond F L. 3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. Am J Hum Genet 200577154–160. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical